Effective: July 24, 2002
Latest Legislation: Senate Bill 4 - 124th General Assembly
As used in sections 3902.22 and 3902.23 of the Revised Code, "third-party payer" has the same meaning as in section 3901.38 of the Revised Code.
Structure Ohio Revised Code
Chapter 3902 | Insurance Policies and Contracts
Section 3902.01 | Purpose of Sections.
Section 3902.02 | Insurance Policy and Contract Definitions.
Section 3902.03 | Policies to Which Sections Apply - Exceptions - Non-English Language Policies.
Section 3902.04 | Requirements for Policy Forms.
Section 3902.05 | Construction.
Section 3902.06 | Superintendent May Authorize Lower Test Score.
Section 3902.07 | Approval of Policy Form Notwithstanding Provisions of Other Laws.
Section 3902.08 | Policy Forms Compliance Date.
Section 3902.11 | Coordination of Benefits Definitions.
Section 3902.12 | Primary or Secondary Health Coverage.
Section 3902.13 | Order of Benefits for Health Coverage Plan.
Section 3902.21 | Standard Claim Form Definitions.
Section 3902.22 | Superintendent to Develop Standard Claim Form.
Section 3902.23 | Use of Form Mandatory.
Section 3902.30 | Coverage for Telehealth Services.
Section 3902.31 | Void Contracts.
Section 3902.36 | Compliance With Federal Mental Health and Addiction Parity Laws.
Section 3902.50 | Definitions for r.c. 3902.50 to 3902.72.
Section 3902.51 | Out-of-Network Care Reimbursement Requirement, Negotiations.
Section 3902.52 | Out-of-Network Care Arbitration.
Section 3902.53 | Out-of-Network Care Rules, Prompt Pay Requirements, Violations.
Section 3902.54 | Out-of-Network Care Arbitrator Requirements.
Section 3902.60 | Advanced Cancer Fail First Drug Coverage Definitions.
Section 3902.61 | Advanced Cancer Fail First Drug Coverage Prohibitions.
Section 3902.62 | Coverage for Drugs Refilled Without a Prescription.
Section 3902.70 | Health Plan Issuer Contracts With 340b Program Participants Definitions.
Section 3902.71 | Health Plan Issuer Contracts With 340b Program Participants.
Section 3902.72 | Health Plan Issuer Disclosure of Drug Data.